Literature DB >> 25559170

Suppression of human macrophage-mediated cytotoxicity by transgenic swine endothelial cell expression of HLA-G.

Emilio L Esquivel1, Akira Maeda1, Hiroshi Eguchi1, Mayumi Asada1, Miku Sugiyama1, Chieko Manabe1, Rieko Sakai1, Rei Matsuura1, Kengo Nakahata1, Hiroomi Okuyama1, Shuji Miyagawa2.   

Abstract

BACKGROUND: Xenotransplantation is an appealing alternative to human allotransplantation because of a worldwide shortage of organs. One of the obstacles for xenografts is cellular rejection by the innate immune system, comprised of NK cells, monocytes, and macrophages. In this study the inhibitory function of HLA-G1, a MHC Ib molecule, on macrophage-mediated cytotoxicity was examined. Furthermore, this study also evaluates the suppressive effect of cytokine production by macrophages.
METHODS: The expression of inhibitory receptors that interact with HLA-G1, immunoglobulin-like transcript 2 (ILT2), ILT4 and KIR2DL4 (CD158d) on in vitro generated macrophages were examined by flow cytometry. Complementary DNA (cDNA) of HLA-G1, HLA-E and human β2-microglobulin (hβ2m) were prepared and transfected into swine endothelial cells (SECs). The expression of the transgenic genes was evaluated by flow cytometry, and macrophage-mediated SEC cytolysis was assessed using the macrophages.
RESULTS: In vitro generated macrophages expressed not only ILT2 and ILT4 but CD158d as well. The transgenic HLA-G1 on SECs indicated significant suppression in macrophage-mediated cytotoxicity, which was equivalent to that of transgenic HLA-E. Furthermore, the results on real time PCR and ELISA revealed that transgenic HLA-G1 induces the anti-inflammatory cytokines, such as IL-10 and TGF-β, and suppresses iNOS mRNA expression, indicating that transgenic HLA-G1 has suppressive effects in a broad range of transplant rejection.
CONCLUSION: These results indicate that generating HLA-G1 transgenic pigs can protect porcine grafts from macrophage-mediated cytotoxicity.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  HLA-G1; ILT2; ILT4; KIR2DL4; Macrophage; Xenotransplantation

Mesh:

Substances:

Year:  2015        PMID: 25559170     DOI: 10.1016/j.trim.2014.12.004

Source DB:  PubMed          Journal:  Transpl Immunol        ISSN: 0966-3274            Impact factor:   1.708


  15 in total

Review 1.  Pig-to-Primate Islet Xenotransplantation: Past, Present, and Future.

Authors:  Zhengzhao Liu; Wenbao Hu; Tian He; Yifan Dai; Hidetaka Hara; Rita Bottino; David K C Cooper; Zhiming Cai; Lisha Mou
Journal:  Cell Transplant       Date:  2017-02-03       Impact factor: 4.064

Review 2.  Genetically-engineered pigs as sources for clinical red blood cell transfusion: What pathobiological barriers need to be overcome?

Authors:  Benjamin Smood; Hidetaka Hara; Leah J Schoel; David K C Cooper
Journal:  Blood Rev       Date:  2019-01-28       Impact factor: 8.250

3.  Transplantation of hepatocytes from genetically engineered pigs into baboons.

Authors:  Hayato Iwase; Hong Liu; Eva Schmelzer; Mohamed Ezzelarab; Martin Wijkstrom; Hidetaka Hara; Whayoung Lee; Jagjit Singh; Cassandra Long; Eric Lagasse; Jörg C Gerlach; David K C Cooper; Bruno Gridelli
Journal:  Xenotransplantation       Date:  2017-01-28       Impact factor: 3.907

4.  Human CD200 suppresses macrophage-mediated xenogeneic cytotoxicity and phagocytosis.

Authors:  Rieko Sakai; Akira Maeda; Thuy-Vy Choi; Pei-Chi Lo; Patmika Jiaravuthisan; Afifah Mod Shabri; Han-Tang Wang; Rei Matsuura; Tasuku Kodama; Hiroshi Eguchi; Hiroomi Okuyama; Shuji Miyagawa
Journal:  Surg Today       Date:  2017-06-01       Impact factor: 2.549

5.  Suppression of xenogeneic innate immune response by a membrane-type human surfactant protein-A.

Authors:  Chiyoshi Toyama; Akira Maeda; Shuhei Kogata; Riho Yamamoto; Kazunori Masahata; Takehisa Ueno; Masafumi Kamiyama; Yuko Tazuke; Hiroshi Eguchi; Hiroomi Okuyama; Shuji Miyagawa
Journal:  Exp Ther Med       Date:  2022-07-26       Impact factor: 2.751

Review 6.  The role of genetically engineered pigs in xenotransplantation research.

Authors:  David K C Cooper; Burcin Ekser; Jagdeece Ramsoondar; Carol Phelps; David Ayares
Journal:  J Pathol       Date:  2015-10-07       Impact factor: 7.996

7.  Recent advances in understanding xenotransplantation: implications for the clinic.

Authors:  David Kc Cooper; Rita Bottino
Journal:  Expert Rev Clin Immunol       Date:  2015-09-01       Impact factor: 4.473

Review 8.  The production of multi-transgenic pigs: update and perspectives for xenotransplantation.

Authors:  Heiner Niemann; Bjoern Petersen
Journal:  Transgenic Res       Date:  2016-01-28       Impact factor: 2.788

9.  Growth Hormone Stops Excessive Inflammation After Partial Hepatectomy, Allowing Liver Regeneration and Survival Through Induction of H2-Bl/HLA-G.

Authors:  Mayumi Ishikawa; Andrew J Brooks; Manuel A Fernández-Rojo; Johan Medina; Yash Chhabra; Shiro Minami; Kathryn A Tunny; Robert G Parton; Julian P Vivian; Jamie Rossjohn; Viral Chikani; Grant A Ramm; Ken K Y Ho; Michael J Waters
Journal:  Hepatology       Date:  2020-11-02       Impact factor: 17.425

Review 10.  The Role of HLA-G in Human Papillomavirus Infections and Cervical Carcinogenesis.

Authors:  Hui-Hui Xu; Wei-Hua Yan; Aifen Lin
Journal:  Front Immunol       Date:  2020-06-25       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.